Associate Editor, Pharmaceutical Executive Europe
This year's Ad Stars embrace creativity through the eyes of the patients. Ben Comer and Jennifer Ringler report.
Jim Currie and Baber Ghauri talk to Pharm Exec about making connections that resonate with audiences in a digital world.
Making real connections that resonate with audiences in a digital world is a fine art, especially in the heavily regulated world of Big Pharma
After two years of waiting, FDA issued the first in a series of planned guidelines on social media at the end of last year. We look at some of the experts' reactions.
Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?
Abbey Meyers, Founder, National Organization of Rare Disorders
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva